Inventor · disambiguated record
Gabriele Wiemer
Also filed as: WIEMER GABRIELE
8 granted patents·1 pending application·140 citations·filing 1989–2001
88Inventor score
Top patents by PatentIndex Score
9 records- 0191US6235766B11-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising themAVENTIS PHARMA GMBH·Filed 2000·Granted May 22, 2001·41 cites·13 claims
- 0281US6429222B21-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising themAVENTIS PHARMA GMBH·Filed 2001·Granted Aug 6, 2002·14 cites·5 claims
- 0373US5231083AMethod for the treatment of cardiac and of vascular hypertrophy and hyperplasiaHOECHST AG·Filed 1990·Granted Jul 27, 1993·29 cites·14 claims
- 0464US5952346AUse of non-peptide bradykinin antagonists for the treatment or prevention of Alzheimer's diseaseHOECHST MARION ROUSSEL DE GMBH·Filed 1997·Granted Sep 14, 1999·25 cites·5 claims
- 0560US5475004AAngiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart diseaseHOECHST AG·Filed 1993·Granted Dec 12, 1995·12 cites·4 claims
- 0655US5612365AAngiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart diseaseHOECHST AG·Filed 1995·Granted Mar 18, 1997·11 cites·9 claims
- 0749US2002077344A11-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical prepartions comprising themAVENTIS PHARMA GMBH·Filed 2001·Application pending·0 cites
- 0845US6245736B1Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's diseaseAVENTIS PHARMA GMBH·Filed 1997·Granted Jun 12, 2001·5 cites·15 claims
- 0944US5091427APiperazinediones having a psychotropic actionHOECHST AG·Filed 1989·Granted Feb 25, 1992·3 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Gabriele Wiemer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →